Evogene Ltd. (EVGN)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ofer Haviv CPA | CEO, President & Director | 423k | -- | 1966 |
| Dr. Elran Hillel Haber M.B.A., Ph.D. | Chief Executive Officer of Biomica Ltd | 251k | -- | 1980 |
| Mr. Yoash Zohar | Chief Executive Officer of Casterra Ag Ltd. | 251k | -- | 1967 |
| Dr. Dan Jacob Gelvan Ph.D. | Chief Executive Officer of Ag Plenus Ltd. | 210k | -- | 1964 |
| Mr. Amit Noam Capt. res. | Chief Executive Officer of Lavie Bio Ltd. | 216k | -- | 1982 |
| Mr. Yaron Eldad | Chief Financial Officer | -- | -- | 1965 |
| Ms. Liat Foigel Wejgman | Vice President of Human Resources | -- | -- | -- |
| Mr. Russ Putland | Executive VP Commercial & General Manager USA | -- | -- | -- |
Evogene Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 117
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
Corporate Governance
Upcoming Events
May 21, 2025 at 12:30 PM UTC
Evogene Ltd. Earnings Date
Recent Events
March 28, 2025 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
September 25, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission